Ongoing research is focused on understanding the pathways through which GLP-1 impacts mental health and evaluating the clinical benefits of these medications in patients with mood disorders
Individual response varies depending on severity and duration of deficiency
Retatrutide, in early data, outperforms tirzepatide suggesting incremental receptor targeting translates to incremental efficacy
Upon stimulation with different small molecules, these EECs secreted 5-HT, CCK, GLP-1, PYY, GIP and SST 6
A significance level of alpha = 0.05 was adopted for all analyses
A 2A receptors and dopamine D 2 receptors interact with each other, and A 2A receptor activation inhibits the function of the D 2 receptor under normal conditions